An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA Gyrase Suppressive Features for The Treatment of Coronaviral & Adenoviral Infections NOVIR

Updated on September 1, 2021 — Creative Commons Attribution 4.0

Mas Pharmaceuticals

Mas Pharmaceuticals is a Bioceutical R&D Performing Biotechnology Company located in Istanbul , Turkey. Mas Pharmaceuticals holds the ownership of 128 Pharmaceutical and Bioceutical Patents' Exclusive License Rights which are invented by Mr. Erdal Can ALKOCLAR and Mr. Metehan YESIL. Mas…

1 datasets

Informations

License
Creative Commons Attribution 4.0
ID
5e9f437dd2bfb22b625b457e

Temporality

Frequency
Quarterly
Creation date
April 21, 2020
Latest resource update
April 21, 2020

Embed

Permalink

Description

An Antiviral Formulation Consisting of 3 Protopanaxatriol-Class Glucopyranoside Analouges , A Semi-Synthetic Flavonol Glycoside Derivative and an Immuno-Modulatory Ginsenoside RG3 Subvariant for The Treatment of Coronaviral & Adenoviral Infections via Suppressing DNA Polymerase, RNA Dependent RNA Polymerase and Viral DNA Gyrase and Modulating Anti-Inflammatory Cytokines Tnf-Alpha, IL-6, Nf-Kappa B and PGE2 to Suppress Potential Cytokine Storms Simultaneously.

Inventors: ERDAL CAN ALKOCLAR & METEHAN YESIL

Files 3

Community resources 0

You have built a more comprehensive database than those presented here? This is the time to share it!

Reuses 0

Explore the reuses of this dataset.

Did you use this data ? Reference your work and increase your visibility.

Discussion between the organization and the community about this dataset.